2016
DOI: 10.4081/mrm.2016.311
|View full text |Cite
|
Sign up to set email alerts
|

Mometasone furoate nasal spray: a systematic review

Abstract: The inflammatory diseases of the nose, rhino-pharynx and paranasal sinuses (allergic and non allergic rhinitis, NARES; rhinosinusitis with/without nasal polyposis, adenoidal hypertrophy with/without middle ear involvement) clinically manifest themselves with symptoms and complications severely affecting quality of life and health care expenditure. Intranasal administration of corticosteroids, being fast, simple, and not requiring cooperation, is the preferred way to treat the patients, to optimize their qualit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
5
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 23 publications
0
5
0
Order By: Relevance
“…Loratadine is widely used for the relief of AR-related symptoms such as sneezing, runny and itchy nose, ocular itching, and burning sensation [16]. Mometasone is a topical glucocorticoid and nasal spray administration exerts local anti-inflammatory effects at doses that do not provoke systemic effects [17]. e combination of loratadine and mometasone furoate has been investigated to be well tolerated and effective in controlling the symptoms of rhinitis [18].…”
Section: Discussionmentioning
confidence: 99%
“…Loratadine is widely used for the relief of AR-related symptoms such as sneezing, runny and itchy nose, ocular itching, and burning sensation [16]. Mometasone is a topical glucocorticoid and nasal spray administration exerts local anti-inflammatory effects at doses that do not provoke systemic effects [17]. e combination of loratadine and mometasone furoate has been investigated to be well tolerated and effective in controlling the symptoms of rhinitis [18].…”
Section: Discussionmentioning
confidence: 99%
“…13,14 The intranasal corticosteroid mometasone effectively reduces SAR symptoms of nasal itching and congestion, sneezing, and rhinorrhea by inhibiting the release of inflammatory mediators and has a well-documented safety profile with minimal systemic effects. [15][16][17][18] The efficacy and safety of US Food and Drug Administration (FDA) −approved olopatadine hydrochloride and mometasone furoate monotherapy nasal sprays have been demonstrated in natural allergen exposure studies 13,14,17,19 and in studies using an environmental exposure chamber (EEC). [20][21][22] The objective of this study was to evaluate the efficacy and safety of once-daily or twice-daily GSP301 treatments vs placebo and 2 FDA-approved nasal sprays, olopatadine 23 and an FDC that contains the antihistamine azelastine hydrochloride and the glucocorticoid fluticasone propionate, 24 in participants with SAR using a ragweed pollen EEC model.…”
Section: Introductionmentioning
confidence: 99%
“…Glucocorticoids can be used in three stages (remission induction, intensification (consolidation) and maintenance) of childhood leukemia, but they are best used during remission induction, with the goal of eliminating more than 99% of the diseased tissue (minimal residual disease) [21]. MF is a synthetic glucocorticoid that induces the synthesis of anti-inflammatory factors as well as the role of immunosuppression [16]. It has minimal side effects.…”
Section: Discussionmentioning
confidence: 99%
“…Mometasone Furoate (MF) is an efficient glucocorticoid for topical treatment of inflammation on the skin, lung and nose [15]. Evidence suggests that the using of MF also improves symptoms associated with adenoid hypertrophy [16]. MF contains hexanediol, which has antimicrobial properties [17].…”
Section: Introductionmentioning
confidence: 99%